IceCure Medical Ltd
ICCM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.41 | 0.55 | 0.21 | -1.93 |
| FCF Yield | -4.20% | -4.85% | -5.95% | -6.87% |
| EV / EBITDA | -15.90 | -16.68 | -17.48 | -12.15 |
| Quality | ||||
| ROIC | -186.78% | -64.34% | -54.98% | -59.09% |
| Gross Margin | 32.59% | 24.95% | 30.07% | 47.66% |
| Cash Conversion Ratio | 0.70 | 0.84 | 1.13 | 0.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.70% | -4.70% | 2.40% | 2.11% |
| Free Cash Flow Growth | 4.41% | 29.96% | 3.69% | -31.87% |
| Safety | ||||
| Net Debt / EBITDA | 1.24 | 0.91 | 1.59 | 1.60 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.21 | 0.17 | 0.25 | 0.23 |
| Cash Conversion Cycle | 256.04 | 491.03 | 361.70 | 171.29 |